News
New research reveals that many patients with low-risk thyroid cancer can safely skip postoperative radioiodine ablation, ...
Brexu-cel demonstrated efficacy and safety even in patients with B-cell acute lymphoblastic leukemia with central nervous ...
A digital app significantly enhances the quality of life for caregivers of stem cell transplant patients, reducing stress and ...
During a live event, Nataliya Mar, MD, discussed systemic therapies such as lenvatinib/pembrolizumab in advanced renal cell ...
A multidisciplinary expert panel issued recommendations on the use of bronchoscopic biopsies in terms of safety and sample ...
The results support the potential for treatment de-escalation after hysterectomy for women with early-stage, ...
A new drug for low-risk MDS is showing a surprising benefit: it's not just improving quality of life, but also extending patients' lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results